Researchers examined the different aspects of screening for anxiety disorders in adults.
FDA says all versions of Novo’s GLP-1 weight loss drugs are now available
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS